We consolidated in 2015 from the three entities (Simcere Biologics Group, Novomab, Third Venture);
Skilled team (60 - 120 staffs) with global and local biologics and pharma experiences;
A pipeline of >10 biologics in clinical and pre-clinical development for oncology and autoimmune diseases;
Integrated discovery, development & manufacturing capabilities and facilities in Shanghai and Nanjing;
Partnerships for cutting-edge antibody platforms (Vaccinia-based screening platform & bispecific ab).
Company Details
- Employees
- 2
- Founded
- -
- Address
- No. 699-18 Xuanwu Avenue, Xuanwu District,china
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- bskbiopharma.com
- Keywords
- In vitro analysis, In vivo biology and animal models, In-house expertise in T cell immunology, and Hybridoma, humanization, phage display, antibody engineering for bispecific ab.
- HQ
- Nanjing, Jiangsu
Bsk Biopharma Questions
Bsk Biopharma's website is bskbiopharma.com
Bsk Biopharma's LinkedIn profile is https://cn.linkedin.com/company/bsk-biopharma
Bsk Biopharma has
2 employees.
View email and phone details for 2
employees at Bsk Biopharma.
Bsk Biopharma's industry is
Biotechnology Research
Bsk Biopharma's top competitors are
Ericsson,
Hengrui Pharma,
Integral Molecular,
Great Bay Bio 大湾生物,
Biospace.
Bsk Biopharma's categories are Biotechnology Research
Bsk Biopharma's founding year is 2015
